Savvipharm Inc Patent applications |
Patent application number | Title | Published |
20120202761 | Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt - This invention is in the field of anthracycline family of drugs. More particularly, it concerns converting daunorubicin hydrochloride to an orotate salt and providing methods of improving the tolerability of daunorubicin in animals by reducing the adverse effects and toxicity in noncancerous tissues. Daunorubicin orotate provides a safer treatment for specific types of leukemias and neuroblastomas in adults and in pediatric patients. | 08-09-2012 |
20120197017 | Pharmaceutical compositions containing paclitaxel orotate - This invention is related to orotic acid compounds of taxane cytotoxic agents and in particular to the conversion of the taxanes to their orotate esters. More particularly the pharmaceutical compositions of paclitaxel orotate and docetaxel orotate provide a strategy to minimize body weight loss during primary chemotherapy and improve patient outcomes and quality of life. | 08-02-2012 |